Johnson & Johnson Medical (Shanghai) Ltd.
Clinical trials sponsored by Johnson & Johnson Medical (Shanghai) Ltd., explained in plain language.
A Chinese subsidiary of Johnson & Johnson, selling medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New mesh stent aims to seal brain aneurysms without surgery
Disease control Recruiting nowThis study is testing a new device called the Choydar flow-directed mesh stent for people with unruptured brain aneurysms—weak spots in blood vessels that could burst. The stent is placed inside the artery to block blood flow into the aneurysm, helping it heal. Researchers will f…
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
6,111 women to track breast implant safety over 5 years
Knowledge-focused Recruiting nowThis study follows 6,111 women in China who received Mentor breast implants to monitor safety and satisfaction over five years. Researchers will record any implant-related side effects, pain levels, and how happy patients are with their results. The goal is to gather real-world d…
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd. • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC